Please login to the form below

Not currently logged in
Email:
Password:

Contract research organisation PRA opens Singapore office

Continues its Asia-Pacific expansion with new centralised operations base

PRA has opened a new office in Singapore that will act as a centralised operations base for its activities in the region.

The US contract research organisation's new facility will provide monitoring, project management, safety reporting, feasibility and other services.

Helen Neal, PRA's director of clinical operations for Asia-Pacific, said: "Building our capability across the region with the centre in Singapore permits our sponsors to experience a wider range of services and expertise.

"This location provides our teams with access to experts and resources within their time zone, positively impacting our speed and quality of delivery on projects."

PRA has been steadily expanding its Asia-Pacific operations since 2000 and its operations in the region also include Korea, Taiwan, China, Hong Kong, Thailand, Australia, New Zealand, and India.

The expansion mirrors investments from the pharma industry in new research operations. Last year Merck & Co pledged $1.5bn to expand its presence in China and Bayer said it expects Asia to account for €11bn of sales by 2015.

24th February 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Growing influence of pharmacists in the sale of Rx and OTC medicines
Find out how the changes within pharmacy have affected their influence over the sales of RX and OTC medicines in this whitepaper....
Drivers of 2014′s Soaring Drug Approvals
The FDA & EMA approved a chart-topping number of new drugs in 2014. Read more in our White Paper about the responsibility this growing approval success will put on future...
Russian innovation at the crossroads
Despite improvements, investors face rising risks...